Issued on behalf of Avaí Bio, Inc. As the broader cell and gene therapy complex posts record quarterly revenue and advances toward accelerated approval pathways, a Nevada-based longevity joint venture ...

THE WOODLANDS, Texas, July 28, 2026 /PRNewswire/ -- Cellipont Bioservices, a cell therapy contract development and manufacturing organization, today announced the successful release of its 100th GMP ...

The Cell Therapy Manufacturing Market is projected to witness rapid expansion as the global biopharmaceutical industry ...

Learn how effective technology transfer helps cell therapy developers navigate GMP manufacturing, regulatory requirements and ...

Amerigo Scientific launched a comprehensive portfolio of GMP-grade proteins tailored to accelerate the development and clinical translation of cell therapies. NEW ...

Cell and gene therapy manufacturing relies on complex cell processing, viral vector production, quality control, and GMP-compliant workflows to consistently produce safe and effective therapies at ...

Over the past decade, our industry has witnessed the promise of cell and gene therapies. Patients with rare diseases or hard-to-treat diagnoses now have treatment options harnessing human cells and ...

Creative Life Science (7837) is showcasing its upstream regenerative medicine materials, process-development capabilities and quality-testing services, highlighting the build-out and service capacity ...

Amerigo Scientific’s protein product line encompasses GMP-grade cytokines and growth factors essential for cell therapy manufacturing. These products are manufactured in adherence to relevant ...